Basic Research
Copyright ©The Author(s) 2005. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Gastroenterol. Aug 28, 2005; 11(32): 4957-4961
Published online Aug 28, 2005. doi: 10.3748/wjg.v11.i32.4957
Effects of dietary supplementation with vitamin E and selenium on rat hepatic stellate cell apoptosis
Xiu-Hua Shen, Wu-Feng Cheng, Xuan-Hai Li, Jian-Qin Sun, Feng Li, Ling Ma, Liang-Min Xie
Xiu-Hua Shen, Wu-Feng Cheng, Xuan-Hai Li, Feng Li, Ling Ma, Department of Nutrition, Shanghai Second Medical University, Shanghai 200025, China
Liang-Min Xie, Department of Nutrition, Shanghai East Hospital, Shanghai 200120, China
Jian-Qin Sun, Department of Nutrition, Huadong Hospital, Shanghai 200040, China
Author contributions: All authors contributed equally to the work.
Supported by the Science Research Foundation of Ministry of Public Health of China, No. 98-2-280
Correspondence to: Dr. Xiu-Hua Shen, Department of Nutrition, Shanghai Second Medical University, 280 South Chongqin Road, Shanghai 200025, China. srachel@sina.com
Telephone: +86-210-63846590-776507
Received: August 18, 2004
Revised: December 1, 2004
Accepted: December 3, 2004
Published online: August 28, 2005
Abstract

AIM: To evaluate the effects of dietary supplementation with vitamin E and selenium on proliferation and apoptosis of hepatic stellate cells (HSCs), in acute liver injury induced by CCl4, and to explore their role in the recovery from hepatic fibrosis phase.

METHODS: An acute liver damage model of rats was established by intraperitoneal injection of carbon tetrachloride (0.3 mL/100 g body weight) twice a week, then the rats were killed at 6, 24, 48, and 72 h after the first and third injection, respectively. A liver fibrosis model was established by the same injection for 8 wk. Then three rats were killed at 3, 7, 14, and 28 d after the last injection, respectively. The rats from the intervention group were fed with chow supplemented with vitamin E (250 mg/kg) and selenium (0.2 mg/kg), and the rats in the normal control group and pathological group were given standard chow. Livers were harvested and stained with hematoxylin and eosin, Sirius red. Activated HSCs were determined by α-smooth muscle actin immunohistochemistry staining. Apoptotic HSCs were determined by dual staining with the terminal deoxynucleotidyl transferase UTP nick end labeling (TUNEL) and α-smooth muscle actin immunohistochemistry. Serum alanine aminotransferase and aspartate aminotransferase were also analyzed.

RESULTS: In the acute liver damage model, the degree of liver injury was more serious in the pathological group than in the intervention group. At each time point, the number of activated HSCs was less in the intervention group than in the pathological group, while the number of apoptotic HSCs was more in the intervention group than in the pathological group. In the liver fibrosis model, the degree of liver fibrosis was more serious in the pathological group than in the intervention group. At each time point, the number of activated HSCs was less in the intervention group than in the pathological group, and the number of apoptotic HSCs was more in the intervention group than in the pathological group.

CONCLUSION: Vitamin E and selenium supplementation at the given level can inhibit CCl4-induced activation and proliferation of HSCs and promote the apoptosis of activated HSCs in acute damage phase. Vitamin E and selenium can also effectively decrease the degree of hepatic fibrosis and promote the recovery process.

Keywords: Vitamin E, Selenium, Hepatic stellate cell, Apoptosis